PharmiWeb
Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of
(NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing ...
7 days ago